Sufer (iron (III)) solution for intravenous injections 20 mg/ml. 5 ml. №5

$169.40

Manufacturer: Ukraine

Purpose: Iron supplement for anemia treatment through intravenous injection.

SKU: MED61489 Categories: ,

Description

Sufer (iron (III)) solution for intravenous injections 20 mg/ml. 5 ml. №5

Ingredients

Each 5 ml contains 100 mg of iron (III).

Dosage

The recommended dosage is determined by a healthcare provider based on individual needs. It is typically administered intravenously at a rate of 1 ml per minute.

Indications

Sufer solution is indicated for the treatment of iron deficiency anemia in patients who cannot tolerate oral iron supplementation. It is also used in cases where rapid iron replenishment is necessary.

Contraindications

Do not use Sufer solution if you have iron overload conditions such as hemochromatosis or hemosiderosis. It is also contraindicated in patients with known hypersensitivity to iron products.

Directions

Administer under the supervision of a healthcare professional experienced in intravenous therapy. Monitor for signs of an allergic reaction during administration.

Scientific Evidence

Studies have shown that intravenous iron therapy, such as Sufer solution, is effective in rapidly correcting iron deficiency anemia. Research published in the Journal of Hematology & Oncology demonstrated that intravenous iron therapy is well-tolerated and can lead to significant improvements in hemoglobin levels and quality of life in patients with iron deficiency anemia.

Additional Information

It is important to perform a test dose prior to the full administration of Sufer solution to check for any potential allergic reactions. Patients should be monitored closely during and after the infusion for any adverse effects.

Pharmacological Effects: Sufer solution provides a direct and rapid increase in iron levels in the body, supporting the production of hemoglobin and red blood cells. This helps alleviate symptoms of anemia and improves overall health and well-being.

Clinical Trials: A randomized controlled trial published in the British Journal of Haematology compared the efficacy of intravenous iron therapy with oral iron supplementation in patients with iron deficiency anemia. The study concluded that intravenous iron was more effective in improving hemoglobin levels and replenishing iron stores, highlighting the importance of intravenous iron therapy in certain patient populations.